Gp120 in the pathogenesis of human immunodeficiency virus-associated pain

Annals of Neurology

Volumn 75, Issue 6, 2014, Pages 837-850

  Yuan, Su Bo ^a   Shi, Yuqiang ^a   Chen, Jinghong ^a   Zhou, Xiangfu ^b   Li, Guangyu ^a   Gelman, Benjamin B ^a   Lisinicchia, Joshua G ^a   Carlton, Susan M ^a   Ferguson, Monique R ^a   Tan, Alai ^a   Sarna, Sushil K ^a   Tang, Shao Jun ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CHRONIC PAIN; DISEASE ASSOCIATION; GLIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE FIBER; NONHUMAN; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; SYNAPSE; SYNAPTIC TRANSMISSION; VIRUS LOAD; WESTERN BLOTTING;

ADULT; ANIMALS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; FEMALE; GANGLIA, SPINAL; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; HYPERALGESIA; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PAIN; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SPINAL CORD; VIRAL LOAD;

EID: 84903708844     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24139     Document Type: Article

References (72)

1. Gendelman HE, Grant I, Everall IP, et al. The neurobiology of AIDS. 3rd ed. Oxford, UK: Oxford University Press, 2012.
2. Hewitt DJ, McDonald M, Portenoy RK, et al. Pain syndromes and etiologies in ambulatory AIDS patients. Pain 1997; 70: 117.
3. Mirsattari SM, Power C, Nath A,. Primary headaches in HIV-infected patients. Headache 1999; 39: 3.
4. Evers S, Wibbeke B, Reichelt D, et al. The impact of HIV infection on primary headache. Unexpected findings from retrospective, cross-sectional, and prospective analyses. Pain 2000; 85: 191.
5. Aouizerat BE, Miaskowski CA, Gay C, et al. Risk factors and symptoms associated with pain in HIV-infected adults. J Assoc Nurses AIDS Care 2010; 21: 125-133.
6. Griffin JW, Crawford TO, Tyor WR, et al. Predominantly sensory neuropathy in AIDS: distal axonal degeneration and unmyelinated fiber loss. Neurology 1991; 41: 374.
7. Wallace VCJ, Blackbeard J, Segerdahl AR, et al. Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain 2007; 130: 2688-2702.
8. Milligan ED, Mehmert KK, Hinde JL, et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res 2000; 861: 105.
9. Herzberg U, Sagen J,. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J Neuroimmunol 2001; 116: 29.
10. Milligan ED, O'Connor KA, Nguyen KT, et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 2001; 21: 2808-2819.
11. Oh SB, Tran PB, Gillard SE, et al. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 2001; 21: 5027-5035.
12. Keswani SC, Jack C, Zhou C, Hoke A,. Establishment of a rodent model of HIV-associated sensory neuropathy. J Neurosci 2006; 26: 10299-10304.
13. Wallace VCJ, Blackbeard J, Pheby T, et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 2007; 133: 47.
14. Zheng W, Ouyang H, Zheng X, et al. Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain 2011; 7: 40.
15. Acharjee S, Noorbakhsh F, Stemkowski PL, et al. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain. FASEB J 2010; 24: 4343-4353.
16. Bhangoo S, Ripsch M, Buchanan D, et al. Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain 2009; 5: 48.
17. Höke A, Morris M, Haughey NJ,. GPI-1046 protects dorsal root ganglia from gp120-induced axonal injury by modulating store-operated calcium entry. J Peripher Nerv Syst 2009; 14: 27-35.
18. Melli G, Keswani SC, Fischer A, et al. Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain 2006; 129: 1330-1338.
19. Keswani SC, Leitz GJ, Hoke A,. Erythropoietin is neuroprotective in models of HIV sensory neuropathy. Neurosci Lett 2004; 371: 102.
20. Chi X, Amet T, Byrd D, et al. Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain. PLoS ONE 2011; 6: e24412.
21. Morgello S, Gelman BB, Kozlowski PB, et al. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 2001; 27: 326-335.
22. Shi Y, Gelman BB, Lisinicchia JG, Tang S-J,. Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of HIV-infected patients. J Neurosci 2012; 32: 10833-10840.
23. Hylden JLK, Wilcox GL,. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980; 67: 313.
24. Callahan BL, Gil AS, Levesque A, Mogil JS,. Modulation of mechanical and thermal nociceptive sensitivity in the laboratory mouse by behavioral state. J Pain 2008; 9: 174-184.
25. Winston JH, Xu G, Sarna SK,. Adrenergic stimulation mediates visceral hypersensitivity to colorectal distension following heterotypic chronic stress. Gastroenterology 2010; 138: 294-304.
26. Kwong PD, Wyatt R, Robinson J, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998; 393: 648.
27. Romani B, Engelbrecht S, Glashoff RH,. Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol 2010; 91: 1-12.
28. Magnuson DS, Knudsen BE, Geiger JD, et al. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995; 37: 373-380.
29. Newshan G,. Pain in human immunodeficiency virus disease. Semin Oncol Nurs 1997; 13: 36-41.
30. Winston JH, Sarna SK,. Developmental origins of functional dyspepsia-like gastric hypersensitivity in rats. Gastroenterology 2013; 144: 570-579.
31. Evans SR, Ellis RJ, Chen H, et al. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS 2011; 25: 919-928.
32. Cao L, Butler MB, Tan L, et al. Murine immunodeficiency virus-induced peripheral neuropathy and the associated cytokine responses. J Immunol 2012; 189: 3724-3733.
33. Kellogg AP, Wiggin TD, Larkin DD, et al. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 2007; 56: 2997-3005.
34. Ko M-H, Chen W-P, Hsieh S-T,. Neuropathology of skin denervation in acrylamide-induced neuropathy. Neurobiol Dis 2002; 11: 155.
35. Compostella C, Compostella L, D'Elia R,. The symptoms of autonomic dysfunction in HIV-positive Africans. Clin Auton Res 2008; 18: 6-12.
36. Boger MS, Hulgan T, Haas DW, et al. Measures of small-fiber neuropathy in HIV infection. Auton Neurosci 2012; 169: 56-61.
37. Kamerman PR, Moss PJ, Weber J, et al. Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models. J Peripher Nerv Syst 2012; 17: 19-31.
38. Watkins LR, Deak T, Silbert L, et al. Evidence for involvement of spinal cord glia in diverse models of hyperalgesia. Proc Soc Neurosci 1995; 21: 879.
39. Ji R-R, Baba H, Brenner GJ, Woolf CJ,. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 1999; 2: 1114.
40. Jin S-X, Zhuang Z-Y, Woolf CJ, Ji R-R,. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003; 23: 4017-4022.
41. Gao YJ, Ji RR,. c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? Open Pain J 2009; 2: 11-17.
42. Gao Y-J, Cheng J-K, Zeng Q, et al. Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model. Exp Neurol 2009; 219: 146.
43. Gao Y-J, Xu Z-Z, Liu Y-C, et al. The c-Jun N-terminal kinase 1 (JNK1) in spinal astrocytes is required for the maintenance of bilateral mechanical allodynia under a persistent inflammatory pain condition. Pain 2010; 148: 309.
44. Fang L, Wu J, Lin Q, Willis WD,. Calcium-calmodulin-dependent protein kinase II contributes to spinal cord central sensitization. J Neurosci 2002; 22: 4196-4204.
45. Crown ED, Gwak YS, Ye Z, et al. Calcium/calmodulin dependent kinase II contributes to persistent central neuropathic pain following spinal cord injury. Pain 2012; 153: 710-721.
46. Bouhassira D, Attal N, Willer J-C, Brasseur L,. Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation. Pain 1999; 80: 265-272.
47. Elliott KJ, McArthur JC, Simpson DM,. Peripheral neuropathy. In:, Gendelman HE, Grant I, Everall IP, et al, eds. The neurology of AIDS. 3rd ed. Oxford, UK: Oxford University Press, 2012: 536-545.
48. Pandey V, Bolsover SR,. Immediate and neurotoxic effects of HIV protein gp120 act through CXCR4 Receptor. Biochem Biophys Res Commun 2000; 274: 212-215.
49. Kaul M, Lipton SA,. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 1999; 96: 8212-8216.
50. Nath A, Haughey NJ, Jones M, et al. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 2000; 47: 186-194.
51. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB,. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991; 7: 111.
52. Lannuzel A, Lledo PM, Lamghitnia HO, et al. HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons. Eur J Neurosci 1995; 7: 2285-2293.
53. Dreyer E, Kaiser P, Offermann J, Lipton S,. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990; 248: 364-367.
54. Keswani SC, Polley M, Pardo CA, et al. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 2003; 54: 287.
55. Garrison CJ, Dougherty PM, Kajander KC, Carlton SM,. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 1991; 565: 1-7.
56. Gao Y-J, Zhang L, Samad OA, et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 2009; 29: 4096-4108.
57. Gao Y-J, Zhang L, Ji R-R,. Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1. Glia 2010; 58: 1871.
58. Gwak YS, Hulsebosch CE,. Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat. Neuroscience 2009; 161: 895-903.
59. Hulsebosch CE,. Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury. Exp Neurol 2008; 214: 6-9.
60. Zhuang Z-Y, Wen Y-R, Zhang D-R, et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 2006; 26: 3551-3560.
61. Zhang H, Yoon S-Y, Zhang H, Dougherty PM,. Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of paclitaxel-induced painful neuropathy. J Pain 2012; 13: 293-303.
62. Leung L, Cahill C,. TNF-alpha and neuropathic pain-a review. J Neuroinflammation 2010; 7: 27.
63. Ren K, Torres R,. Role of interleukin-1β during pain and inflammation. Brain Res Rev 2009; 60: 57.
64. Kim HJ, Shin AH, Thayer SA,. Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss. Mol Pharmacol 2011; 80: 357-366.
65. Toggas SM, Masliah E, Rockenstein EM, et al. Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice. Nature 1994; 367: 188-193.
66. Maung R, Medders K, Sejbuk N, et al. Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury. J Neuroimmune Pharmacol 2012; 7: 306-318.
67. Wiley CA, Masliah E, Morey M, et al. Neocortical damage during HIV infection. Ann Neurol 1991; 29: 651-657.
68. Everall IP, Heaton RK, Marcotte TD, et al. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. Brain Pathol 1999; 9: 209-217.
69. Latremoliere A, Woolf CJ,. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10: 895-926.
70. Gao Y-J, Ji R-R,. Activation of JNK pathway in persistent pain. Neurosci Lett 2008; 437: 180.
71. Gao Y-J, Ji R-R,. Light touch induces ERK activation in superficial dorsal horn neurons after inflammation: involvement of spinal astrocytes and JNK signaling in touch-evoked central sensitization and mechanical allodynia. J Neurochemistry 2010; 115: 505.
72. Ji R-R, Gereau RW IV, Malcangio M, Strichartz GR,. MAP kinase and pain. Brain Res Rev 2009; 60: 135-148.